CD8+ T cell differentiation status correlates with the feasibility of sustained unresponsiveness following oral immunotherapy.
Kaushik A, Dunham D, Han X, Do E, Andorf S, Gupta S, Fernandes A, Kost LE, Sindher SB, Yu W, Tsai M, Tibshirani R, Boyd SD, Desai M, Maecker HT, Galli SJ, Chinthrajah RS, DeKruyff RH, Manohar M, Nadeau KC.
Kaushik A, et al. Among authors: han x.
Nat Commun. 2022 Nov 4;13(1):6646. doi: 10.1038/s41467-022-34222-8.
Nat Commun. 2022.
PMID: 36333296
Free PMC article.
Clinical Trial.